Morse, Bednarczyk Named to New Posts in UB Pharmacy School

By Mary Cochrane

Release Date: May 15, 2007 This content is archived.


BUFFALO, N.Y. -- The University at Buffalo School of Pharmacy and Pharmaceutical Sciences has named Gene D. Morse as associate dean of clinical and translational research and Edward M. Bednarczyk to succeed Morse as chair of the Department of Pharmacy Practice.

Morse, a professor in the pharmacy practice department with additional appointments in medicine and pediatrics, served as department chair for the past 11 years and as associate dean for clinical education and research since 2000. He directs the school's Pharmacotherapy Research Center.

Morse also directs the Translational Pharmacology Core Research Group in UB's New York State Center of Excellence in Bioinformatics and Life Sciences and the UB Clinical and Translational Sciences Research Institute. The institute was created to foster interactions among and research involving faculty in the five schools in UB's Academic Health Center and to position the university to compete successfully for National Institutes of Health (NIH) funding in clinical and translational sciences.

Morse's research focuses on HIV and AIDS, as well as antiretroviral pharmacology. He is principal investigator for the NIH AIDS Clinical Trials Group UB Pharmacology Specialty Laboratory.

Morse has developed HIV pharmacology training for clinical evaluation of antiretroviral therapy in acute care and ambulatory settings, established an HIV certificate program, a post-doctoral pharmacy residency program and a post-doctoral fellowship program in HIV/AIDS pharmacology. He has led the implementation and growth of the HIV Adherence-Pharmacology Unit at the Erie County Medical Center in collaboration with the UB Division of Infectious Diseases.

A UB faculty member since 1983, he received the SUNY Chancellor's Award for Excellence in Scholarship and Creative Activity in 2004.  A graduate of the University of Albany, Morse earned a bachelor's degree and doctorate in pharmacy from UB.

He is a resident of Williamsville.

Bednarczyk, who directs the pharmacy school's clinical education programs, has been a UB clinical associate professor since 2002. His research focuses on the application of molecular imaging

such as PET to understand drug effects and he has several areas of therapeutic focus, including migraine headaches. He has served as the director of the Clinical and Translational Research Center, jointly operated by the VAMC and UB.

Bednarczyk earned a bachelor's degree in pharmacy from UB and a doctoral degree in pharmacy from the Medical University of South Carolina College of Pharmacy. He completed a hospital pharmacy residency at The Buffalo General Hospital and a post-doctoral fellowship in clinical cardiovascular pharmacology at Case Western Reserve University/University Hospitals of Cleveland.

He lives in Cheektowaga.

The University at Buffalo is a premier research-intensive public university, the largest and most comprehensive campus in the State University of New York. UB's more than 27,000 students pursue their academic interests through more than 300 undergraduate, graduate and professional degree programs. Founded in 1846, the University at Buffalo is a member of the Association of American Universities.